This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kohn, E. C. Articles by Liotta, L. A. Search for Related Content PubMed PubMed Citation Articles by Kohn, E. C. Articles by Liotta, L. A.

Molecular Insights into Cancer Invasion: Strategies for Prevention and Intervention

Laboratory of Pathology, Division of Cancer Biology, Diagnosis and Centers, National Cancer Institute, NIH, Bethesda, Maryland 28092

The diagnosis and treatment of solid tumors usually begins at a late stage when most patients already have occult or overt metastasis. Many years of cancer progression precede diagnosis of most solid tumors. Novel noncytotoxic therapeutics may be specially suited for administration during this interval. An important window of intervention can be defined as the period during which transition from a hyperproliferative state to acquisition of the capacity for invasion and metastasis occurs. Investigation of the molecular basis of invasion is uncovering strategies for delaying progression of preinvasive carcinoma and treatment of primary tumors and established metastasis. Although tumor cell invasion might not be rate limiting for the growth of metastasis, anti-invasive agents can block tumor angiogenesis and thereby indirectly block metastasis growth. Two classes of molecular anti-invasion targets exist: (a) cell surface and extracellular proteins, which mediate sensing, adhesion, and proteolysis; and (b) signal transduction pathways, which regulate invasion, angiogenesis, and proliferation. Both categories of targets yield treatment approaches that are now being tested in the clinic. Metalloproteinase inhibitors, such as BB94, are based on the recognition that metalloproteinases play a necessary role in invasion and angiogenesis. The orally active signal transduction inhibitor carboxyamidotriazole modulates non-voltage-gated calcium influx-regulated signal pathways and reversibly inhibits tumor invasion, growth, and angiogenesis. Blockade of invasion, angiogenesis, or cellular signal pathways is likely to generate a cytostatic, rather than a cytotoxic effect. Cytostatic therapy constitutes an alternative paradigm for clinical translation that may complement conventional cytotoxic therapy. For patients with newly diagnosed solid tumors, long-term cytostatic therapy could potentially create a state of metastasis dormancy or delay the time to overt relapse following cytotoxic agent-induced remission. Clinical toxicity and pharmacology using oral cytostatic agents in phase I trials and in adjuvant settings will provide an important foundation for the translation of this approach to the preinvasive carcinoma period.

Received 12/30/94. Accepted 2/23/95.

This article has been cited by other articles:

				E. J. Kim, M. Shin, H. Park, J. E. Hong, H.-K. Shin, J. Kim, D. Y. Kwon, and J. H. Y. Park Oral Administration of 3,3'-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice J. Nutr., December 1, 2009; 139(12): 2373 - 2379. [Abstract] [Full Text] [PDF]

				H. ENGI, N. GYEMANT, M. OHKOSHI, L. AMARAL, and J. MOLNAR Modelling of Tumour--Host Coexistence In Vitro in the Presence of Serine Protease Inhibitors In Vivo, September 1, 2009; 23(5): 711 - 715. [Abstract] [Full Text] [PDF]

				A. Fokine, K. A. Miroshnikov, M. M. Shneider, V. V. Mesyanzhinov, and M. G. Rossmann Structure of the Bacteriophage {varphi}KZ Lytic Transglycosylase gp144 J. Biol. Chem., March 14, 2008; 283(11): 7242 - 7250. [Abstract] [Full Text] [PDF]

				C.-J. Weng, C.-F. Chau, Y.-S. Hsieh, S.-F. Yang, and G.-C. Yen Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-{kappa}B and AP-1 Carcinogenesis, January 1, 2008; 29(1): 147 - 156. [Abstract] [Full Text] [PDF]

				D. Shen, C. Deng, and M. Zhang Peroxisome proliferator-activated receptor {gamma} agonists inhibit the proliferation and invasion of human colon cancer cells Postgrad. Med. J., June 1, 2007; 83(980): 414 - 419. [Abstract] [Full Text] [PDF]

				T. A. Dunn, S. Chen, D. A. Faith, J. L. Hicks, E. A. Platz, Y. Chen, C. M. Ewing, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, et al. A Novel Role of Myosin VI in Human Prostate Cancer Am. J. Pathol., November 1, 2006; 169(5): 1843 - 1854. [Abstract] [Full Text] [PDF]

				O. Mignen, C. Brink, A. Enfissi, A. Nadkarni, T. J. Shuttleworth, D. R. Giovannucci, and T. Capiod Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells J. Cell Sci., December 1, 2005; 118(23): 5615 - 5623. [Abstract] [Full Text] [PDF]

				P. A. Nony, S. B. Kennett, W. C. Glasgow, K. Olden, and J. D. Roberts 15(S)-Lipoxygenase-2 Mediates Arachidonic Acid-stimulated Adhesion of Human Breast Carcinoma Cells through the Activation of TAK1, MKK6, and p38 MAPK J. Biol. Chem., September 9, 2005; 280(36): 31413 - 31419. [Abstract] [Full Text] [PDF]

				R. J. Epstein Maintenance Therapy to Suppress Micrometastasis: The New Challenge for Adjuvant Cancer Treatment Clin. Cancer Res., August 1, 2005; 11(15): 5337 - 5341. [Abstract] [Full Text] [PDF]

				T. Yoshii, K. Mizuno, T. Hirose, A. Nakajima, H. Sekihara, and S. Ohno sPAR-3, a splicing variant of PAR-3, shows cellular localization and an expression pattern different from that of PAR-3 during enterocyte polarization Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G564 - G570. [Abstract] [Full Text] [PDF]

				M. Zou, K. S. Famulski, R. S. Parhar, E. Baitei, F. A. Al-Mohanna, N. R. Farid, and Y. Shi Microarray Analysis of Metastasis-Associated Gene Expression Profiling in a Murine Model of Thyroid Carcinoma Pulmonary Metastasis: Identification of S100A4 (Mts1) Gene Overexpression as a Poor Prognostic Marker for Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6146 - 6154. [Abstract] [Full Text] [PDF]

				T.-W. CHUNG, S.-K. MOON, Y.-C. CHANG, J.-H. KO, Y.-C. LEE, G. CHO, S.-H. KIM, J.-G. KIM, and C.-H. KIM Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism FASEB J, November 1, 2004; 18(14): 1670 - 1681. [Abstract] [Full Text] [PDF]

				J. Pandey, A. Bannout, and D. L. Wendell The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor Carcinogenesis, October 1, 2004; 25(10): 1829 - 1838. [Abstract] [Full Text] [PDF]

				A. Paju, J. Vartiainen, C. Haglund, O. Itkonen, K. von Boguslawski, A. Leminen, T. Wahlstrom, and U.-H. Stenman Expression of Trypsinogen-1, Trypsinogen-2, and Tumor-Associated Trypsin Inhibitor in Ovarian Cancer: Prognostic Study on Tissue and Serum Clin. Cancer Res., July 15, 2004; 10(14): 4761 - 4768. [Abstract] [Full Text] [PDF]

				Y. Shintani, S. Higashiyama, M. Ohta, H. Hirabayashi, S. Yamamoto, T. Yoshimasu, H. Matsuda, and N. Matsuura Overexpression of ADAM9 in Non-Small Cell Lung Cancer Correlates with Brain Metastasis Cancer Res., June 15, 2004; 64(12): 4190 - 4196. [Abstract] [Full Text] [PDF]

				M. Suzuki, H. Kobayashi, N. Kanayama, Y. Saga, M. Suzuki, C.-Y. Lin, R. B. Dickson, and T. Terao Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase J. Biol. Chem., April 9, 2004; 279(15): 14899 - 14908. [Abstract] [Full Text] [PDF]

				G. Gamberi, M. S. Benassi, P. Ragazzini, L. Pazzaglia, F. Ponticelli, C. Ferrari, A. Balladelli, M. Mercuri, M. Gigli, F. Bertoni, et al. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone Ann. Onc., March 1, 2004; 15(3): 498 - 503. [Abstract] [Full Text] [PDF]

				C. F. Singer, N. Kronsteiner, G. Hudelist, E. Marton, I. Walter, M. Kubista, K. Czerwenka, M. Schreiber, M. Seifert, and E. Kubista Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: Interleukin 1{alpha} Protein Secretion Is Correlated with Malignant Phenotype Clin. Cancer Res., October 15, 2003; 9(13): 4877 - 4883. [Abstract] [Full Text] [PDF]

				G. Giannelli, E. Fransvea, C. Bergamini, F. Marinosci, and S. Antonaci Laminin-5 Chains Are Expressed Differentially in Metastatic and Nonmetastatic Hepatocellular Carcinoma Clin. Cancer Res., September 1, 2003; 9(10): 3684 - 3691. [Abstract] [Full Text] [PDF]

				O. GOLDSHMIDT, E. ZCHARIA, M. COHEN, H. AINGORN, I. COHEN, L. NADAV, B.-Z. KATZ, B. GEIGER, and I. VLODAVSKY Heparanase mediates cell adhesion independent of its enzymatic activity FASEB J, June 1, 2003; 17(9): 1015 - 1025. [Abstract] [Full Text] [PDF]

				C. M. John, H. Leffler, B. Kahl-Knutsson, I. Svensson, and G. A. Jarvis Truncated Galectin-3 Inhibits Tumor Growth and Metastasis in Orthotopic Nude Mouse Model of Human Breast Cancer Clin. Cancer Res., June 1, 2003; 9(6): 2374 - 2383. [Abstract] [Full Text] [PDF]

				M. Dohadwala, R. K. Batra, J. Luo, Y. Lin, K. Krysan, M. Pold, S. Sharma, and S. M. Dubinett Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion J. Biol. Chem., December 20, 2002; 277(52): 50828 - 50833. [Abstract] [Full Text] [PDF]

				C. Yu, K. Pan, D. Xing, G. Liang, W. Tan, L. Zhang, and D. Lin Correlation between a Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter and Risk of Lung Cancer Cancer Res., November 15, 2002; 62(22): 6430 - 6433. [Abstract] [Full Text] [PDF]

				G. L. Rosner, W. Stadler, and M. J. Ratain Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents J. Clin. Oncol., November 15, 2002; 20(22): 4478 - 4484. [Abstract] [Full Text] [PDF]

				N. Mori, H. Sato, T. Hayashibara, M. Senba, T. Hayashi, Y. Yamada, S. Kamihira, S. Ikeda, Y. Yamasaki, S. Morikawa, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness Blood, February 15, 2002; 99(4): 1341 - 1349. [Abstract] [Full Text] [PDF]

				S. Saad, D. J. Gottlieb, K. F. Bradstock, C. M. Overall, and L. J. Bendall Cancer Cell-associated Fibronectin Induces Release of Matrix Metalloproteinase-2 from Normal Fibroblasts Cancer Res., January 1, 2002; 62(1): 283 - 289. [Abstract] [Full Text] [PDF]

				E. C. Kohn, E. Reed, G. A. Sarosy, L. Minasian, K. S. Bauer, F. Bostick-Bruton, V. Kulpa, E. Fuse, A. Tompkins, M. Noone, et al. A Phase I Trial of Carboxyamido-triazole and Paclitaxel for Relapsed Solid Tumors: Potential Efficacy of the Combination and Demonstration of Pharmacokinetic Interaction Clin. Cancer Res., June 1, 2001; 7(6): 1600 - 1609. [Abstract] [Full Text] [PDF]

				G. Konecny, M. Untch, A. Pihan, R. Kimmig, M. Gropp, P. Stieber, H. Hepp, D. Slamon, and M. Pegram Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer Clin. Cancer Res., June 1, 2001; 7(6): 1743 - 1749. [Abstract] [Full Text] [PDF]

				B. A. Niemeyer, C. Bergs, U. Wissenbach, V. Flockerzi, and C. Trost Competitive regulation of CaT-like-mediated Ca2+ entry by protein kinase C and calmodulin PNAS, March 13, 2001; 98(6): 3600 - 3605. [Abstract] [Full Text] [PDF]

				J. I. Williams, S. Weitman, C. M. Gonzalez, C. H. Jundt, J. Marty, S. D. Stringer, K. J. Holroyd, M. P. McLane, Q. Chen, M. Zasloff, et al. Squalamine Treatment of Human Tumors in nu/nu Mice Enhances Platinum-based Chemotherapies Clin. Cancer Res., March 1, 2001; 7(3): 724 - 733. [Abstract] [Full Text]

				N. Mitsiades, W.-h. Yu, V. Poulaki, M. Tsokos, and I. Stamenkovic Matrix Metalloproteinase-7-mediated Cleavage of Fas Ligand Protects Tumor Cells from Chemotherapeutic Drug Cytotoxicity Cancer Res., January 1, 2001; 61(2): 577 - 581. [Abstract] [Full Text]

				L. G. M. Hazen, F. E. Bleeker, B. Lauritzen, S. Bahns, J. Song, A. Jonker, B. E. M. Van Driel, H. Lyon, U. Hansen, A. Köhler, et al. Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer J. Histochem. Cytochem., October 1, 2000; 48(10): 1421 - 1430. [Abstract] [Full Text]

				J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37. [Abstract] [Full Text] [PDF]

				A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF]

				E. Sunami, N. Tsuno, T. Osada, S. Saito, J. Kitayama, S. Tomozawa, T. Tsuruo, Y. Shibata, T. Muto, and H. Nagawa MMP-1 is a Prognostic Marker for Hematogenous Metastasis of Colorectal Cancer Oncologist, April 1, 2000; 5(2): 108 - 114. [Abstract] [Full Text]

				G. Vona, A. Sabile, M. Louha, V. Sitruk, S. Romana, K. Schutze, F. Capron, D. Franco, M. Pazzagli, M. Vekemans, et al. Isolation by Size of Epithelial Tumor Cells : A New Method for the Immunomorphological and MolecularCharacterization of Circulating Tumor Cells Am. J. Pathol., January 1, 2000; 156(1): 57 - 63. [Abstract] [Full Text] [PDF]

				J. E. Park, M. C. Lenter, R. N. Zimmermann, P. Garin-Chesa, L. J. Old, and W. J. Rettig Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts J. Biol. Chem., December 17, 1999; 274(51): 36505 - 36512. [Abstract] [Full Text] [PDF]

				S. Al-Haddad, Z. Zhang, E. Leygue, L. Snell, A. Huang, Y. Niu, T. Hiller-Hitchcock, K. Hole, L. C. Murphy, and P. H. Watson Psoriasin (S100A7) Expression and Invasive Breast Cancer Am. J. Pathol., December 1, 1999; 155(6): 2057 - 2066. [Abstract] [Full Text] [PDF]

				D. S. Goodsell The Molecular Perspective: Matrix Metalloproteinase 2 Oncologist, December 1, 1999; 4(6): 509 - 511. [Full Text]

				N. Mitsiades, V. Poulaki, A. Leone, and M. Tsokos Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors J Natl Cancer Inst, October 6, 1999; 91(19): 1678 - 1684. [Abstract] [Full Text] [PDF]

				Y. Kanamori, M. Matsushima, T. Minaguchi, K. Kobayashi, S. Sagae, R. Kudo, N. Terakawa, and Y. Nakamura Correlation between Expression of the Matrix Metalloproteinase-1 Gene in Ovarian Cancers and an Insertion/Deletion Polymorphism in Its Promoter Region Cancer Res., September 1, 1999; 59(17): 4225 - 4227. [Abstract] [Full Text] [PDF]

				A. H. Ree, M. Tvermyr, O. Engebraaten, M. Rooman, O. Rosok, E. Hovig, L. A. Meza-Zepeda, O. S. Bruland, and O. Fodstad Expression of a Novel Factor in Human Breast Cancer Cells with Metastatic Potential Cancer Res., September 1, 1999; 59(18): 4675 - 4680. [Abstract] [Full Text] [PDF]

				A. K. Sood, J. I. Sorosky, M. Dolan, B. Anderson, and R. E. Buller Distant Metastases in Ovarian Cancer: Association with p53 Mutations Clin. Cancer Res., September 1, 1999; 5(9): 2485 - 2490. [Abstract] [Full Text] [PDF]

				E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, G. Schneider, and K. Tryggvason Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed Science, June 4, 1999; 284(5420): 1667 - 1670. [Abstract] [Full Text]

				D.L. Crowe, G.E. Milo, and C.E. Shuler Keratin 19 Downregulation by Oral Squamous Cell Carcinoma Lines Increases Invasive Potential Journal of Dental Research, June 1, 1999; 78(6): 1256 - 1263. [Abstract] [PDF]

				C. Ries, F. Loher, C. Zang, M. G. Ismair, and P. E. Petrides Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes Clin. Cancer Res., May 1, 1999; 5(5): 1115 - 1124. [Abstract] [Full Text] [PDF]

				S. Manes, E. Mira, C. Gomez-Mouton, Z. J. Zhao, R. A. Lacalle, and C. Martinez-A. Concerted Activity of Tyrosine Phosphatase SHP-2 and Focal Adhesion Kinase in Regulation of Cell Motility Mol. Cell. Biol., April 1, 1999; 19(4): 3125 - 3135. [Abstract] [Full Text] [PDF]

				E. Mira, S. Mañes, R. A. Lacalle, G. Márquez, and C. Martínez-A Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9 Endocrinology, April 1, 1999; 140(4): 1657 - 1664. [Abstract] [Full Text]

				A. Price, Q. Shi, D. Morris, M. E. Wilcox, P. M. A. Brasher, N. B. Rewcastle, D. Shalinsky, H. Zou, K. Appelt, R. N. Johnston, et al. Marked Inhibition of Tumor Growth in a Malignant Glioma Tumor Model by a Novel Synthetic Matrix MetalloproteinaseInhibitor AG3340 Clin. Cancer Res., April 1, 1999; 5(4): 845 - 854. [Abstract] [Full Text] [PDF]

				L. Yao, C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 Blood, March 1, 1999; 93(5): 1612 - 1621. [Abstract] [Full Text] [PDF]

				G I Murray, M E Duncan, E Arbuckle, W T Melvin, and J E Fothergill Matrix metalloproteinases and their inhibitors in gastric cancer Gut, December 1, 1998; 43(6): 791 - 797. [Abstract] [Full Text] [PDF]

				E.A. Seftor, R.E.B. Seftor, D.R.C. Nieva, and M.J.C. Hendrix Application of Chemically Modified Tetracyclines (CMTs) in Experimental Models of Cancer and Arthritis Advances in Dental Research, November 1, 1998; 12(1): 103 - 110. [PDF]

				I. Massova, L. P. Kotra, R. Fridman, and S. Mobashery Matrix metalloproteinases: structures, evolution, and diversification FASEB J, September 1, 1998; 12(12): 1075 - 1095. [Abstract] [Full Text]

				K. Lampert, U. Machein, M. R. Machein, W. Conca, H. H. Peter, and B. Volk Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors Am. J. Pathol., August 1, 1998; 153(2): 429 - 437. [Abstract] [Full Text] [PDF]

				T. Andreu, T. Beckers, E. Thoenes, P. Hilgard, and H. von Melchner Gene Trapping Identifies Inhibitors of Oncogenic Transformation. THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) AND COLLAGEN TYPE I alpha 2 (COL1A2) ARE EPIDERMAL GROWTH FACTOR-REGULATED GROWTH REPRESSORS J. Biol. Chem., May 29, 1998; 273(22): 13848 - 13854. [Abstract] [Full Text] [PDF]

				T. H. Bugge, K. W. Kombrinck, Q. Xiao, K. Holmback, C. C. Daugherty, D. P. Witte, and J. L. Degen Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice Blood, December 1, 1997; 90(11): 4522 - 4531. [Abstract] [Full Text] [PDF]

				N. M. Mazure, E. Y. Chen, K. R. Laderoute, and A. J. Giaccia Induction of Vascular Endothelial Growth Factor by Hypoxia Is Modulated by a Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Ha-ras-Transformed Cells Through a Hypoxia Inducible Factor-1 Transcriptional Element Blood, November 1, 1997; 90(9): 3322 - 3331. [Abstract] [Full Text] [PDF]

				G. Giannelli, J. Falk-Marzillier, O. Schiraldi, W. G. Stetler-Stevenson, and V. Quaranta Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5 Science, July 11, 1997; 277(5323): 225 - 228. [Abstract] [Full Text]

				D. C. Malins, N. L. Polissar, and S. J. Gunselman Tumor progression to the metastatic state involves structural modifications in DNA markedly different from those associated with primary tumor formation PNAS, November 26, 1996; 93(24): 14047 - 14052. [Abstract] [Full Text] [PDF]

				M. Dohadwala, J. Luo, L. Zhu, Y. Lin, G. J. Dougherty, S. Sharma, M. Huang, M. Pold, R. K. Batra, and S. M. Dubinett Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44 J. Biol. Chem., June 8, 2001; 276(24): 20809 - 20812. [Abstract] [Full Text] [PDF]

				L. H. Liu, G. P. Boivin, V. Prasad, M. Periasamy, and G. E. Shull Squamous Cell Tumors in Mice Heterozygous for a Null Allele of Atp2a2, Encoding the Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2 Ca2+ Pump J. Biol. Chem., July 13, 2001; 276(29): 26737 - 26740. [Abstract] [Full Text] [PDF]